It is given as a subcutaneous injection (under the skin) once weekly. Learn more about where the best place to inject Zepbound is and what a typical dosing schedule looks like for the drug.

On December 19, 2024, the FDA removed tirzepatide injection from its shortage list after slightly over two years. Tirzepatide is the active ingredient of Eli Lilly’s Mounjaro and Zepbound, two ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and weight-loss tirzepatide injection products (Mounjaro and ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out ... It is usually self-administered. “The best place to inject Mounjaro weight-loss pens is in your abdomen ...

Weight-loss injection Mounjaro, or tirzepatide, will be rolled out on the NHS gradually over a 12-year period, starting this year.